| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Dr. Vera M. Nikodem, Building 10, Room 8N317, Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892. E-mail: veran{at}bldg.10.niddk.nih.gov
Thyroid hormone receptors (TR) are ligand-activated transcription
factors that modulate the expression of certain target genes in a
developmental and tissue-specific manner. These specificities are
determined by the tissue distribution of the TR isoforms
1 and ß1,
the structure of the thyroid hormone response element (TRE) bound by
the receptor, and heterodimerization partners. Among these, retinoid X
receptors (RXR) have been recognized as the principal partners for TR.
The present work reports the identification of a novel nuclear protein
from 19-day-old embryonic rat brain that displays a distinct
interaction pattern with TR isoforms at the level of the TRE of two
genes known to be differentially expressed and regulated by thyroid
hormone (T3): the ubiquitous malic enzyme and the
brain-specific myelin basic protein. Electrophoretic gel mobility shift
assays demonstrate that only TRß1 forms a specific complex with the
rat brain nuclear factor on the myelin basic protein-TRE, but not on
the malic enzyme-TRE. Thus, the interaction is selectively determined
by both the receptor isoform and the structure of the TRE. The
expression of this brain nuclear factor is restricted to the perinatal
period, when myelination is sensitive to T3. Gel supershift
assays with RXR-specific antibodies indicate that this factor is not
one of the known RXR isoforms. However, it is most likely a new member
of the RXR subfamily because it could be supershifted with an antibody
raised against the highly conserved DNA-binding domain of RXRs.
This article has been cited by other articles:
![]() |
R Josephson, T Muller, J Pickel, S Okabe, K Reynolds, P. Turner, A Zimmer, and R. McKay POU transcription factors control expression of CNS stem cell-specific genes Development, January 8, 1998; 125(16): 3087 - 3100. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |